Medicare Part B

CMS needs to strengthen its internal controls to ensure Part B drug payment accuracy, OIG finds
CMS needs to strengthen its internal controls to ensure Part B drug payment accuracy, OIG finds
Endpoints
CMS
Medicare
Medicare Part B
Flag link:
US govt addressing Medicare payments for biosimilars
US govt addressing Medicare payments for biosimilars
Pharma Letter
HHS
Medicare
biosimilars
Medicare Part B
Inflation Reduction Act
CMS
Flag link:
Medicare Part B premiums to drop 3% next year, partly due to limited Aduhelm coverage
Medicare Part B premiums to drop 3% next year, partly due to limited Aduhelm coverage
Medical Marketing and Media
Medicare
Medicare Part B
Biogen
Aduhelm
Flag link:
Medicare premiums to remain unchanged after Aduhelm price cut spurs review
Medicare premiums to remain unchanged after Aduhelm price cut spurs review
BioPharma Dive
Medicare
Medicare Part B
Biogen
Aduhelm
HHS
Alzheimer's disease
Flag link:
CMS proposes to Withdraw Trump Era Most Favored Nation (MFN) Drug Pricing Rule
CMS proposes to Withdraw Trump Era Most Favored Nation (MFN) Drug Pricing Rule
FDA Law Blog
HHS
Donald Trump
Medicare
Medicare Part B
most favored nation
drug pricing
Flag link:
New drug launch prices have doubled since 2005
New drug launch prices have doubled since 2005
Beckers Hospital Review
drug pricing
Medicare
Medicare Part B
Flag link:
Most Favored Nation Drug Pricing Rule on Hold Awaiting Changes
Most Favored Nation Drug Pricing Rule on Hold Awaiting Changes
FDA Law Blog
drug pricing
Medicare Part B
most favored nation
Flag link:
The 10 most expensive Part B drugs in 2018
The 10 most expensive Part B drugs in 2018
Beckers Hospital Review
Medicare
Medicare Part B
Flag link:
Part B Update: Hospitals Displacing Physicians, Amid Slow Growth in Drug Prices
Part B Update: Hospitals Displacing Physicians, Amid Slow Growth in Drug Prices
Drug Channels
hospitals
Medicare
Medicare Part B
Flag link:
Report: five companies would take brunt of Trump Part B proposal
Report: five companies would take brunt of Trump Part B proposal
BioCentury
Donald Trump
Medicare Part B
Amgen
Regeneron
Bristol-Myers Squibb
Genentech
Roche
Flag link:
CMS rule cuts reimbursement for new Part B drugs
CMS rule cuts reimbursement for new Part B drugs
BioCentury
Medicare Part B
CMS
reimbursement
physician-administered drugs
Flag link:
Possible Shift in Medicare Drug Organization May Give Pharma Heartburn
Possible Shift in Medicare Drug Organization May Give Pharma Heartburn
TheStreet.com
Medicare
Medicare Part B
Alex Azar
Flag link:
Medicare Part B changes are dead and that’s good for pharma: report
Medicare Part B changes are dead and that’s good for pharma: report
Fierce Pharma
Medicare
Medicare Part B
Donald Trump
Flag link:
Pharma dollars back patient groups that oppose Medicare Part B overhaul
Pharma dollars back patient groups that oppose Medicare Part B overhaul
Stat
patients
Medicare Part B
Flag link:
Pharma dollars went overwhelmingly to lawmakers opposing Medicare Part B overhaul
Pharma dollars went overwhelmingly to lawmakers opposing Medicare Part B overhaul
Stat
Medicare Part B
Medicare
Flag link: